Chemoinformaics analysis of Acteoside
Molecular Weight | 624.592 | nRot | 10 |
Heavy Atom Molecular Weight | 588.304 | nRig | 26 |
Exact Molecular Weight | 624.205 | nRing | 4 |
Solubility: LogS | -2.051 | nHRing | 2 |
Solubility: LogP | -0.328 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 44 | No. of Aromatic Carbocycles | 2 |
nHetero | 15 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 29 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 15 | No. of Arom Bond | 12 |
nHA | 15 | APOL | 84.4645 |
nHD | 9 | BPOL | 45.6635 |
QED | 0.087 |
Synth | 4.727 |
Natural Product Likeliness | 1.817 |
NR-PPAR-gamma | 0.955 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.898 |
HIA | 0.993 |
CACO-2 | -6.449 |
MDCK | 0.0000637 |
BBB | 0.336 |
PPB | 0.933414 |
VDSS | 0.373 |
FU | 0.135483 |
CYP1A2-inh | 0.009 |
CYP1A2-sub | 0.019 |
CYP2c19-inh | 0.026 |
CYP2c19-sub | 0.056 |
CYP2c9-inh | 0.005 |
CYP2c9-sub | 0.373 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.185 |
CYP3a4-inh | 0.027 |
CYP3a4-sub | 0.023 |
CL | 1.702 |
T12 | 0.778 |
hERG | 0.018 |
Ames | 0.389 |
ROA | 0.094 |
SkinSen | 0.687 |
Carcinogencity | 0.077 |
EI | 0.006 |
Respiratory | 0.015 |
NR-Aromatase | 0.895 |
Antiviral | Yes |
Prediction | 0.863446 |